Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models
Thomas Sorz(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Ksenia Brusilovskaya(Austrian Academy of Sciences), Benedikt Simbrunner(Austrian Academy of Sciences), Vlad Țâru(Iuliu Hațieganu University of Medicine and Pharmacy), Philipp Schwabl(Austrian Academy of Sciences), Peng Sun(Tongren Hospital), Ines Truebenbach(Boehringer Ingelheim (Germany)), Katharina Regnat(Medical University of Vienna), Katharina Bonitz(Austrian Academy of Sciences), Carolin Lackner(Ludwig Boltzmann Institute Applied Diagnostics), Michael Trauner(Medical University of Vienna), Oleksandr Petrenko(Austrian Academy of Sciences), Benedikt Hofer(Austrian Academy of Sciences), Henriette Horstmeier(Medical University of Vienna), Stefan G. Kauschke(Boehringer Ingelheim (Germany)), Kerstin Zinober(Medical University of Vienna), Philipp Königshofer(Medical University of Vienna)
Cited by 4
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119